- Home
- FGI vs CNSP Comparison
FGI vs CNSP Comparison
Compare FGI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- CNSP
- Stock Information
- Founded
- FGI 1987
- CNSP 2017
- Country
- FGI United States
- CNSP United States
- Employees
- FGI N/A
- CNSP N/A
- Industry
- FGI Industrial Specialties
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- CNSP Health Care
- Exchange
- FGI Nasdaq
- CNSP Nasdaq
- Market Cap
- FGI 8.1M
- CNSP 6.5M
- IPO Year
- FGI 2022
- CNSP 2019
- Fundamental
- Price
- FGI $0.84
- CNSP $2.71
- Analyst Decision
- FGI
- CNSP Strong Buy
- Analyst Count
- FGI 0
- CNSP 1
- Target Price
- FGI N/A
- CNSP $25.00
- AVG Volume (30 Days)
- FGI 8.0K
- CNSP 1.0M
- Earning Date
- FGI 05-07-2025
- CNSP 03-31-2025
- Dividend Yield
- FGI N/A
- CNSP N/A
- EPS Growth
- FGI N/A
- CNSP N/A
- EPS
- FGI N/A
- CNSP N/A
- Revenue
- FGI $127,180,460.00
- CNSP N/A
- Revenue This Year
- FGI $11.39
- CNSP N/A
- Revenue Next Year
- FGI $6.26
- CNSP N/A
- P/E Ratio
- FGI N/A
- CNSP N/A
- Revenue Growth
- FGI 7.71
- CNSP N/A
- 52 Week Low
- FGI $0.70
- CNSP $2.00
- 52 Week High
- FGI $1.64
- CNSP $1,100.00
- Technical
- Relative Strength Index (RSI)
- FGI 51.00
- CNSP 39.44
- Support Level
- FGI $0.81
- CNSP $2.38
- Resistance Level
- FGI $0.86
- CNSP $3.03
- Average True Range (ATR)
- FGI 0.03
- CNSP 0.33
- MACD
- FGI 0.00
- CNSP 0.04
- Stochastic Oscillator
- FGI 48.31
- CNSP 55.47
Stock Price Comparison Chart: FGI vs CNSP
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.